Flavio Mantelli
CIK: 0002127572
Transaction Breakdown
Open Market Buys (P)1 (50.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (50.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
OKYO
OKYO Pharma Ltd
Officer
Discretionary Trading P&L
Holdings
About Mantelli Flavio
Mantelli Flavio (SEC CIK 0002127572) files insider reports with the SEC as CHIEF MEDICAL OFFICER of OKYO Pharma Ltd (OKYO).
Signal8 holds 3 ownership filings by Mantelli Flavio (1 Form 3, 2 Form 4), filed between Jun 17, 2026 and Aug 7, 2026. Those filings report 2 transactions, the latest on Jul 21, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Mantelli Flavio's filings is in LONDON.
Recent filings by Mantelli Flavio
Other insiders filing for OKYO Pharma Ltd (OKYO)
- BRANCACCIO JOHN P, Director
- Dempsey Robert John, CHIEF EXECUTIVE OFFICER
- JACOB GARY S, CHIEF DEVELOPMENT OFFICER
- CERRONE GABRIELE M, Director
- Patil Rajkumar V., Chief Scientific Officer
- Denoyer Bernard, Director